Reduced Weight Gain with Pioglitazone vs Vildagliptin in CREBRF rs373863828 A-allele Carriers: Insights from the WORTH Trial
在CREBRF rs373863828 A等位基因携带者中，吡格列酮与维格列汀相比可减少体重增加：来自WORTH试验的启示
期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S500336
Toomata, Zanetta L L; Jiang, Yannan; Yeu, Rui Qian; Brandon, Rebecca; Tweedie-Cullen, Ry Yves; Nehren, Norma; Doherty, Glenn; Watson, Huti; Macaskill-Smith, Kerry A; Leask, Megan; Merriman, Tony R; Paul, Ryan; Merry, Troy L; Shepherd, Peter R; Murphy, Rinki
